Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
Molecules (Basel, Switzerland)|June 12, 2013
Arylsulfonylamino-benzanilides as inhibitors of the apical sodium-dependent bile salt transporter (SLC10A2)Hong-Tao Liu, Hong-Wei He, Xiao-Guang Bai, et al.Molecular Carcinogenesis|July 17, 2013
Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β-catenin pathwayYi Chen, Dongke Yu, Caixia Zhang, et al.Molecular Biology and Evolution|October 14, 2009
A worldwide survey of human male demographic history based on Y-SNP and Y-STR data from the HGDP-CEPH populationsWentao Shi, Qasim Ayub, Mark Vermeulen, et al.European Journal of Medicinal Chemistry|May 16, 2014
Novel N-substituted sophoridinol derivatives as anticancer agentsChong-Wen Bi, Cai-Xia Zhang, Ying-Hong Li, et al.Cancer Gene Therapy|September 18, 2004
Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancerTie-gang Liu, James Q Yin, Bo-yang Shang, et al.Journal of Drug Targeting|May 17, 2019
Role of co- and post-translational modifications of SFKs in their kinase activationMei-Lian Cai, Meng-Yan Wang, Cong-Hui Zhang, et al.BMC Ophthalmology|March 8, 2020
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanismWen-Ping Song, Si Zheng, Hong-Juan Yao, et al.Acta Pharmacologica Sinica|January 15, 2020
The novel quinolizidine derivate IMB-HDC inhibits STAT5a phosphorylation at 694 and 780 and promotes DNA breakage and cell apoptosis via blocking STAT5a nuclear translocationWu-Li Zhao, Yan Xing, Cheng Ye, et al.Journal of Drug Targeting|June 28, 2019
Role and molecular mechanism of stem cells in colorectal cancer initiationMeng-Yan Wang, Yu-Han Qiu, Mei-Lian Cai, et al.British Journal of Pharmacology|October 18, 2019
Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradationMao-Xu Ge, Hong-Tao Liu, Na Zhang, et al.Pageof 9